REal World Information on Cardiovascular Drug Management Patterns in Acute Coronary Syndrome paTients
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- AstraZeneca
- 入组人数
- 814
- 试验地点
- 1
- 主要终点
- Short-term antithrombotic management patterns (AMPs) in a real-life setting for patients hospitalized with an ACS
研究概览
简要总结
RE-ACT is a national, multi-centre, observational, prospective, longitudinal cohort study which will include patients hospitalized for ACS within 24 hours of symptom onset and who have a final diagnosis of ST-segment elevation myocardial infarction (STEMI) or non-ST-segment elevation myocardial infarction (NSTEMI). This study aims to describe the short-term (at the end of the first month after index event) antithrombotic management patterns in a "real-life" setting for patients hospitalized with an acute coronary syndrome.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Provision of subject informed consent
- •Patients hospitalized and diagnosed with STEMI or NSTEMI
- •Hospitalized within 24 hours of onset of symptoms or transferred from another hospital within 24 hours of the onset of symptoms
排除标准
- •STEMI and NSTEMI precipitated by or as a complication of surgery, trauma, or GI bleeding or post-PCI.
- •STEMI and NSTEMI occurring in patients already hospitalized for other reasons.
- •Presence of any condition/circumstance which in the opinion of the investigator could significantly limit the complete follow up of the patient (e.g. tourist, non-native speaker or does not understand the local language, psychiatric disturbances).
结局指标
主要结局
Short-term antithrombotic management patterns (AMPs) in a real-life setting for patients hospitalized with an ACS
时间窗: Baseline
Descriptive statistics will be calculated for this outcome measure using frequency tables (n, frequency and percentage). Antithrombotic management patterns will be grouped taking into account only the different treatment options shown by the descriptive analysis.
次要结局
- Impact of the different AMPs on quality of life at the end of the first month after discharge from the hospital (using EuroQoL-5D).(At the end of the first month after index event)
- Impact of the different AMPs on quality of life at discharge from hospital (using EuroQoL-5D).(Baseline)
- Variations in the acute clinical management strategies and AMPs.(Baseline)
- Determinants of AMP choices (i.e. patient's characteristics, hospital characteristics, coronary intervention strategies and type of coronary stents used)(Baseline)